HCWB (HCW Biologics Inc.) Forvard P/E multiplikatori
HCW Biologics Inc. (HCWB) saraton va qarishga qarshi immunoterapiyalarni ishlab chiqishda ilmiy tan olinishga tayanadi. Ushbu GURU.Markets grafigi kompaniyaning joriy prognoz qilingan P/E koeffitsiyentini aks ettiradi, bunda 0.00 ushbu metrika uchun yangi qiymatga aylanadi. Robotlashtirilgan proteinlar tahlili dori vositalarini ishlab chiqishni tezlashtiradi, yallig'lanishga qarshi kurashishga bo'lgan barqaror bozor qiziqishi esa brendning ilmiy profilining ishonchliligini tasdiqlaydi.
HCW Biologics Inc. kompaniyasining tahliliy kesimlari
- joriy narx va aksiyalarning prognoz qilingan qiymati:
- biznesning bozor baholash ko'rsatkichlari:
- balans kapitallashuvi haqida ma'lumot:
- qarzdorlik va likvidlik to'g'risida ma'lumotlar:
Umumiy qarzning xususiy kapitalga nisbati HCW Biologics Inc.|HCWB - Uzoq muddatli qarzning kapitalga nisbati|Qisqa muddatli qarzning o'z kapitaliga nisbati HCW Biologics Inc|HCWB - Kompaniyaning jamlangan qarzi|Balans kapitallashuviga qarzlar HCW Biologics, Inc.|HCWB - Uzoq muddatli qarz|Kompaniyaning qisqa muddatli qarzlari HCW Biologics|Tezkor likvidlik koeffitsiyenti hcwbiologics.com
- kompaniyaning daromadliligi va baholash multiplikatorlari ko'rsatkichlari:
HCWB - Sof daromad|Kelajakdagi foyda HCW Biologics Inc.|HCWB - Narx-foyda koeffitsiyenti|Prognoz qilingan narxning foydaga nisbati HCW Biologics, Inc.|HCWB - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|EV/EBITDA multiplikatori HCW Biologics|HCWB - Foizlar, soliqlar va eskirish to'lanishidan oldingi foyda|Bir aksiya uchun sof foyda (EPS TTM) HCW Biologics|HCWB - So'nggi to'rtta chorak uchun bir aksiya uchun sof foyda|So'nggi o'n ikki oy davomida bir aksiya uchun foydaning yillik o'sishi hcwbiologics.com|HCWB - Joriy yilda bir aksiya uchun foydaning o'sish sur'ati|Keyingi yil uchun bir aksiya uchun sof foyda o'sishi prognozi HCW Biologics Inc.
- umumiy tushum va sotuv hajmi ma'lumotlari:
Kompaniyaning jamlanma tahliliyoti:HCW Biologics
HCW Biologics Inc. (HCWB) rivojlanishi yallig'lanishga qarshi oqsillar uchun klinik sinovlarning muvaffaqiyatiga va hamkorlardan litsenziyalash to'lovlarining o'z vaqtida amalga oshirilishiga bog'liq. Kompaniyaning konsensus P/E prognozini tahlil qilib, investor joriy aksiya narxini kutilayotgan daromadlar bilan bog'laydi, bunda egri chiziqning keskin og'ishlari aktivning qadrsizlanganligini yoki fundamental ko'rsatkichlarning qat'iy muvofiqlik nazoratini talab qiluvchi kritik delisting xatarlarini anglatadi.
HCW Biologics Inc. (HCWB) raqobatchilari
Prognoz qilingan narxning foydaga nisbati ARGX (Argenx)|BNTX (BioNTech Group) - Kelajakdagi narx-foyda multiplikatori|Forvard P/E multiplikatori ABVX (Abivax SA)|Kapitalizatsiyaning prognoz qilingan foydaga nisbati admabiologics.com (ADMA)|PTGX - Kelajakdagi narxning foydaga nisbati|Immunovant Inc (IMVT) - Prognoz qilingan narxning foydaga nisbati|Kiniksa Corp (KNSA) - Kelajakdagi narxning foydaga nisbati|Prognoz qilingan narxning foydaga nisbati Grifols, S.A.|Prognoz qilingan narxning foydaga nisbati ADPT|Forvard P/E multiplikatori celldex.com|Kelajakdagi narxning foydaga nisbati Aurinia Pharma (AUPH)|BioCryst Pharmaceuticals - Narxning kelajakdagi foydaga nisbati|Forvard P/E multiplikatori VERA (veratx.com)|Dianthus Pharma (DNTH) - Prognoz qilingan narx-foyda nisbati|PHVS - Kelajakdagi narxning foydaga nisbati|ABCL - Forvard P/E multiplikatori|Tourmaline (TRML) - Kelajakdagi narxning foydaga nisbati|Precigen - Kelajakdagi narx-foyda multiplikatori|PHAR (Pharming Group NV) - Forvard P/E multiplikatori|Forvard P/E multiplikatori Nektar Therapeutics|Kelajakdagi narxning foydaga nisbati Upstream Bio Inc (UPB)|Forvard P/E multiplikatori zenasbio.com (ZBIO)|Kelajakdagi narxning foydaga nisbati Immunome Corp IMNM|Forvard P/E multiplikatori Gossamer Bio Inc GOSS|KALV - Kelajakdagi narxning foydaga nisbati|Kelajakdagi narx-foyda multiplikatori SEPN (Septerna Pharma)|PVLA (Pieris Pharmaceuticals) - Prognoz qilingan narxning foydaga nisbati|Savara Inc. - Kelajakdagi narx-foyda multiplikatori|RIGL (Rigel Pharmaceuticals, Inc.) - Forvard P/E multiplikatori|Kelajakdagi narxning foydaga nisbati ANAB|Forvard P/E multiplikatori ATXS|ENGN - Prognoz qilingan narx-foyda nisbati|Forvard P/E multiplikatori RAPT (rapt.com)|Kapitalizatsiyaning kelajakdagi foydaga nisbati JBIO (Aerovate)|Aclaris Therapeutics, Inc - Forvard P/E multiplikatori|Prognoz qilingan narx-foyda nisbati Kyverna Therapeutics Inc.|TLSA: Forvard P/E multiplikatori|CABA - Kapitalizatsiyaning prognoz qilingan foydaga nisbati|VTYX (ventyxbio.com) - Forvard P/E multiplikatori|Prognoz qilingan narx-foyda nisbati Theratechnologies Inc. THTX|Prognoz qilingan narxning foydaga nisbati AVTX (avalotx.com)|Prognoz qilingan narxning foydaga nisbati Eledon Pharmaceuticals, Inc. ELDN|Kelajakdagi narxning foydaga nisbati Agenus, Inc AGEN|Climb Bio Inc - Kelajakdagi narxning foydaga nisbati|Zura Bio Limited - Forvard P/E multiplikatori|Kapitalizatsiyaning prognoz qilingan foydaga nisbati aTyr Pharma, Inc. ATYR|ADAG: Forvard P/E multiplikatori|Narxning kutilayotgan foydaga nisbati IMA (ImageneBio)|Prognoz qilingan narxning foydaga nisbati STTK|EQ: Kelajakdagi narx-foyda multiplikatori|Kelajakdagi narxning foydaga nisbati Connect Pharma (CNTB)|Forvard P/E multiplikatori Immunic Therapeutics (IMUX)|Forvard P/E multiplikatori ATRA (Atara Biotherapeutics)|Kelajakdagi narx-foyda multiplikatori IFRX|XFOR (X4 Pharma) - Prognoz qilingan narx-foyda nisbati|Kelajakdagi narx-foyda multiplikatori ACET (adicetbio.com)|CELU: Forvard P/E multiplikatori|inmunebio.com (INMB) - Forvard P/E multiplikatori|BRNS (Barinthus Biotherapeutics PLC) - Forvard P/E multiplikatori|KZR: Kelajakdagi narx-foyda multiplikatori|Kelajakdagi narxning foydaga nisbati SAB Biotherapeutics, Inc. (SABS)|AKTX (Akari Therapeutics plc) - Kelajakdagi narx-foyda multiplikatori|Kelajakdagi narxning foydaga nisbati Enlivex Therapeutics Ltd ENLV|QTTB - Prognoz qilingan narxning foydaga nisbati|geovax.com - Forvard P/E multiplikatori|Kelajakdagi narx-foyda multiplikatori EDSA (Edesa Biotech Inc)|IBIO: Forvard P/E multiplikatori|Carisma Tx (CARM) - Forvard P/E multiplikatori|XTLB (XTL Biopharmaceuticals) - Forvard P/E multiplikatori|BOLT: Kelajakdagi narx-foyda multiplikatori|Forvard P/E multiplikatori APVO|AIM - Prognoz qilingan narx-foyda nisbati|Forvard P/E multiplikatori ADTX (Aditxt Inc.)|Kapitalizatsiyaning prognoz qilingan foydaga nisbati GRI Bio, Inc. (GRI)|XRTX - Kelajakdagi narxning foydaga nisbati|reshapelifesciences.com (HIND) - Prognoz qilingan narxning foydaga nisbati|REVB: Forvard P/E multiplikatori|Indaptus Therapeutics, Inc. - Kelajakdagi narx-foyda multiplikatori|Kelajakdagi narxning foydaga nisbati Scinai|Prognoz qilingan narx-foyda nisbati CalciMedica, Inc. CALI|Kelajakdagi narxning foydaga nisbati Affimed NV (AFMD)|Forvard P/E multiplikatori Allakos Inc (ALLK)|Kelajakdagi narxning foydaga nisbati hookipapharma.com HOOK|Forvard P/E multiplikatori IGM Biosciences, Inc. IGMS|iTeos Pharma - Forvard P/E multiplikatori|OCEA - Forvard P/E multiplikatori|TCBP: Forvard P/E multiplikatori|Third Harmonic Bio - Kelajakdagi narx-foyda multiplikatori
